IP Verse

Methods For Treating Atopic Dermatitis By Administering An Il 4r Antagonist - EP2892927

PATENT ANALYSIS

Patent Details

Grant Date: May 9, 2018
Company: REGENERON PHARMACEUTICALS, INC.
Oppositions

More patents of Regeneron Pharmaceuticals, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you